Bafna Pharmaceuticals Ltd (BAFP)

Currency in INR
291.10
+13.60(+4.90%)
Closed·
Trading near 52-week High
BAFP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
278.00291.35
52 wk Range
94.77291.35
Key Statistics
Bid/Ask
289.00 / 291.35
Prev. Close
277.5
Open
278
Day's Range
278-291.35
52 wk Range
94.77-291.35
Volume
25.18K
Average Volume (3m)
27.4K
1-Year Change
193.1816%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BAFP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 11, 2026
EPS / Forecast
0.03 / --
Revenue / Forecast
265.83M / --
EPS Revisions
Last 90 days

BAFP Income Statement

Compare BAFP to Peers and Sector

Metrics to compare
BAFP
Peers
Sector
Relationship
P/E Ratio
84.3x34.1x−0.4x
PEG Ratio
−12.590.000.00
Price/Book
6.8x3.1x2.6x
Price / LTM Sales
4.6x3.9x3.1x
Upside (Analyst Target)
-6.0%47.0%
Fair Value Upside
Unlock−9.0%5.6%Unlock

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. The company operates as a subsidiary of SRJR Lifesciences LLP.

Employees
339
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
20.88M88.28%5.86B
Public Companies & Retail Investors
2.77M11.72%778.26M
Total
23.66M100.00%6.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SRJR Lifesciences LLP74.57%17,640,0164,949,788
M7 Global Fund PCC6.33%1,497,217420,119

People Also Watch

3,310.25
KWAL
+1.37%
1,152.10
SUDP
+1.59%
1,804.40
RUBI
-1.99%
1,482.10
SENO
+0.51%

FAQ

What Is the Bafna Pharmaceuticals (BAFP) Stock Price Today?

The Bafna Pharmaceuticals stock price today is 291.10 INR.

What Stock Exchange Does Bafna Pharmaceuticals Trade On?

Bafna Pharmaceuticals is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Bafna Pharmaceuticals?

The stock symbol for Bafna Pharmaceuticals is "BAFP."

What Is the Bafna Pharmaceuticals Market Cap?

As of today, Bafna Pharmaceuticals market cap is 6.89B INR.

What Is Bafna Pharmaceuticals's Earnings Per Share (TTM)?

The Bafna Pharmaceuticals EPS (TTM) is 3.24.

From a Technical Analysis Perspective, Is BAFP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bafna Pharmaceuticals Stock Split?

Bafna Pharmaceuticals has split 1 times.

How Many Employees Does Bafna Pharmaceuticals Have?

Bafna Pharmaceuticals has 339 employees.

What is the current trading status of Bafna Pharmaceuticals (BAFP)?

As of Aug 29, 2026, Bafna Pharmaceuticals (BAFP) is trading at a price of 291.10 INR, with a previous close of 277.50 INR. The stock has fluctuated within a day range of 278.00 INR to 291.35 INR, while its 52-week range spans from 94.77 INR to 291.35 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.